
PaySign Inc (PAYS) Stock Forecast & Price Target
PaySign Inc (PAYS) Analyst Ratings
Bulls say
PaySign is experiencing strong revenue growth, with a 51% increase year-over-year. Additionally, the company has seen significant growth in adjusted EBITDA, with a 113% increase year-over-year. Management has affirmed their guidance, indicating continued growth in both revenue and adjusted EBITDA over the next few years. This strong financial performance, along with the company's focus on developing innovative payment solutions for various industries and its success in gaining market share, leads to a positive outlook for PaySign's stock.
Bears say
PaySign is a financially sound company, but their performance and 51% Y/Y growth in revenue is inflated due to their recent acquisition of Gamma Innovation LLC. The acquisition may help the company lower technology development costs, but it also comes with a significant upfront payment and additional potential payouts. Furthermore, Paysign's success is heavily dependent on its niche market in plasma donor incentive compensation prepaid cards, making it vulnerable to any changes in that industry.
This aggregate rating is based on analysts' research of PaySign Inc and is not a guaranteed prediction by Public.com or investment advice.
PaySign Inc (PAYS) Analyst Forecast & Price Prediction
Start investing in PaySign Inc (PAYS)
Order type
Buy in
Order amount
Est. shares
0 shares